These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28683472)

  • 1. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
    Alonso MH; Aussó S; Lopez-Doriga A; Cordero D; Guinó E; Solé X; Barenys M; de Oca J; Capella G; Salazar R; Sanz-Pamplona R; Moreno V
    Br J Cancer; 2017 Jul; 117(3):421-431. PubMed ID: 28683472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.
    Loo LW; Tiirikainen M; Cheng I; Lum-Jones A; Seifried A; Church JM; Gryfe R; Weisenberger DJ; Lindor NM; Gallinger S; Haile RW; Duggan DJ; Thibodeau SN; Casey G; Le Marchand L
    Genes Chromosomes Cancer; 2013 May; 52(5):450-66. PubMed ID: 23341073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.
    Yoshida T; Kobayashi T; Itoda M; Muto T; Miyaguchi K; Mogushi K; Shoji S; Shimokawa K; Iida S; Uetake H; Ishikawa T; Sugihara K; Mizushima H; Tanaka H
    Cancer Inform; 2010 Jul; 9():147-61. PubMed ID: 20706620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains.
    Berg KCG; Sveen A; Høland M; Alagaratnam S; Berg M; Danielsen SA; Nesbakken A; Søreide K; Lothe RA
    Oncogene; 2019 Aug; 38(33):6109-6122. PubMed ID: 31308487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.
    Xie T; D' Ario G; Lamb JR; Martin E; Wang K; Tejpar S; Delorenzi M; Bosman FT; Roth AD; Yan P; Bougel S; Di Narzo AF; Popovici V; Budinská E; Mao M; Weinrich SL; Rejto PA; Hodgson JG
    PLoS One; 2012; 7(7):e42001. PubMed ID: 22860045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.
    Ali H; Bitar MS; Al Madhoun A; Marafie M; Al-Mulla F
    PLoS One; 2017; 12(2):e0171690. PubMed ID: 28231327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on 16p13.3 Locus in Colon Cancer.
    Mampaey E; Fieuw A; Van Laethem T; Ferdinande L; Claes K; Ceelen W; Van Nieuwenhove Y; Pattyn P; De Man M; De Ruyck K; Van Roy N; Geboes K; Laurent S
    PLoS One; 2015; 10(7):e0131421. PubMed ID: 26222184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.
    van den Broek E; Krijgsman O; Sie D; Tijssen M; Mongera S; van de Wiel MA; Belt EJ; den Uil SH; Bril H; Stockmann HB; Ylstra B; Carvalho B; Meijer GA; Fijneman RJ
    Oncotarget; 2016 Nov; 7(45):73876-73887. PubMed ID: 27729614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.
    Bacolod MD; Barany F
    J Mol Diagn; 2010 Sep; 12(5):552-61. PubMed ID: 20709793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma.
    Kurashina K; Yamashita Y; Ueno T; Koinuma K; Ohashi J; Horie H; Miyakura Y; Hamada T; Haruta H; Hatanaka H; Soda M; Choi YL; Takada S; Yasuda Y; Nagai H; Mano H
    Cancer Sci; 2008 Sep; 99(9):1835-40. PubMed ID: 18564138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
    Brosens RP; Haan JC; Carvalho B; Rustenburg F; Grabsch H; Quirke P; Engel AF; Cuesta MA; Maughan N; Flens M; Meijer GA; Ylstra B
    J Pathol; 2010 Aug; 221(4):411-24. PubMed ID: 20593488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.
    Williams JL; Greer PA; Squire JA
    Cancer Genet; 2014; 207(10-12):474-88. PubMed ID: 25434580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
    Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
    PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.